Fluorise T Eye Drop contains Tobramycin 0.3% w/v + Fluorometholone 0.1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while controlling associated inflammation. Its combination ensures rapid infection management with steroidal symptom relief.
Tobramycin works by inhibiting bacterial protein synthesis, effectively eliminating susceptible ocular pathogens, while Fluorometholone reduces inflammation, redness, and discomfort, supporting faster recovery.
From a commercial perspective, Fluorise T Eye Drop is a widely prescribed ophthalmic steroid-antibiotic combination, suitable for eye clinics, hospitals, and post-operative care, ensuring consistent demand and repeat prescriptions.
Including Fluorise T Eye Drop in your portfolio strengthens the ophthalmic steroid-antibiotic segment, providing long-term business growth, high prescriber confidence, and enhanced portfolio credibility for PCD pharma franchise partners.